These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 28199769)

  • 21. Design, Synthesis and Anxiolytic Activity Evaluation of N-Acyltryptophanyl- Containing Dipeptides, Potential TSPO Ligands.
    Gudasheva TA; Deeva OA; Mokrov GV; Dyabina AS; Yarkova MA; Seredenin SB
    Med Chem; 2019; 15(4):383-399. PubMed ID: 30457052
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Crystal structures of human factor Xa complexed with potent inhibitors.
    Maignan S; Guilloteau JP; Pouzieux S; Choi-Sledeski YM; Becker MR; Klein SI; Ewing WR; Pauls HW; Spada AP; Mikol V
    J Med Chem; 2000 Aug; 43(17):3226-32. PubMed ID: 10966741
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Identification of AcAP5 as a novel factor Xa inhibitor with both direct and allosteric inhibition.
    Zhu Y; Lin Y; Liu X; Hu W; Wang Y
    Biochem Biophys Res Commun; 2017 Jan; 483(1):495-501. PubMed ID: 28007598
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Design, synthesis, and biological activity of novel tetrahydropyrazolopyridone derivatives as FXa inhibitors with potent anticoagulant activity.
    Sun X; Hong Z; Liu M; Guo S; Yang D; Wang Y; Lan T; Gao L; Qi H; Gong P; Liu Y
    Bioorg Med Chem; 2017 May; 25(10):2800-2810. PubMed ID: 28389110
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Qualitative and quantitative pharmacophore-similarity assessment of anthranilamide-based factor Xa inhibitors: applications on similar molecules with identical biological endpoints.
    Kumar SP; Rawal RM; Pandya HA; Jasrai YT
    J Recept Signal Transduct Res; 2016; 36(2):189-206. PubMed ID: 26416308
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Design, synthesis and biological evaluation of novel 2,3-dihydroquinazolin- 4(1H)-one derivatives as potential fXa inhibitors.
    Xing J; Yang L; Yang Y; Zhao L; Wei Q; Zhang J; Zhou J; Zhang H
    Eur J Med Chem; 2017 Jan; 125():411-422. PubMed ID: 27689724
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Edoxaban, a direct factor Xa inhibitor, suppresses tissue-factor induced human platelet aggregation and clot-bound factor Xa in vitro: Comparison with an antithrombin-dependent factor Xa inhibitor, fondaparinux.
    Honda Y; Kamisato C; Morishima Y
    Thromb Res; 2016 May; 141():17-21. PubMed ID: 26962981
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Design and quantitative structure-activity relationship of 3-amidinobenzyl-1H-indole-2-carboxamides as potent, nonchiral, and selective inhibitors of blood coagulation factor Xa.
    Matter H; Defossa E; Heinelt U; Blohm PM; Schneider D; Müller A; Herok S; Schreuder H; Liesum A; Brachvogel V; Lönze P; Walser A; Al-Obeidi F; Wildgoose P
    J Med Chem; 2002 Jun; 45(13):2749-69. PubMed ID: 12061878
    [TBL] [Abstract][Full Text] [Related]  

  • 29. New factor Xa inhibitors based on 1,2,3,4-tetrahydroquinoline developed by molecular modelling.
    Ilin I; Lipets E; Sulimov A; Kutov D; Shikhaliev K; Potapov A; Krysin M; Zubkov F; Sapronova L; Ataullakhanov F; Sulimov V
    J Mol Graph Model; 2019 Jun; 89():215-224. PubMed ID: 30913501
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Identification of the first low-molecular-weight inhibitors of matriptase-2.
    Sisay MT; Steinmetzer T; Stirnberg M; Maurer E; Hammami M; Bajorath J; Gütschow M
    J Med Chem; 2010 Aug; 53(15):5523-35. PubMed ID: 20684597
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Amido-(propyl and allyl)-hydroxybenzamidines: development of achiral inhibitors of factor Xa.
    Gong Y; Pauls HW; Spada AP; Czekaj M; Liang G; Chu V; Colussi DJ; Brown KD; Gao J
    Bioorg Med Chem Lett; 2000 Feb; 10(3):217-21. PubMed ID: 10698439
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Design, synthesis, and biological activity of potent and selective inhibitors of blood coagulation factor Xa.
    Willardsen JA; Dudley DA; Cody WL; Chi L; McClanahan TB; Mertz TE; Potoczak RE; Narasimhan LS; Holland DR; Rapundalo ST; Edmunds JJ
    J Med Chem; 2004 Jul; 47(16):4089-99. PubMed ID: 15267248
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Design, synthesis, and structure-activity and structure-pharmacokinetic relationship studies of novel [6,6,5] tricyclic fused oxazolidinones leading to the discovery of a potent, selective, and orally bioavailable FXa inhibitor.
    Xue T; Ding S; Guo B; Zhou Y; Sun P; Wang H; Chu W; Gong G; Wang Y; Chen X; Yang Y
    J Med Chem; 2014 Sep; 57(18):7770-91. PubMed ID: 25179681
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Multicomponent reactions in fungicide research: the discovery of mandipropamid.
    Lamberth C; Jeanguenat A; Cederbaum F; De Mesmaeker A; Zeller M; Kempf HJ; Zeun R
    Bioorg Med Chem; 2008 Feb; 16(3):1531-45. PubMed ID: 17962029
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Design, synthesis and evaluation of isoxazolo[5,4-d]pyrimidin-4(5H)-one derivatives as antithrombotic agents.
    Yang J; Su G; Ren Y; Chen Y
    Bioorg Med Chem Lett; 2015 Feb; 25(3):492-5. PubMed ID: 25559742
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Microfluidic Chip-Based Online Screening Coupled to Mass Spectrometry: Identification of Inhibitors of Thrombin and Factor Xa.
    Iyer JK; Otvos RA; Kool J; Kini RM
    J Biomol Screen; 2016 Feb; 21(2):212-20. PubMed ID: 26323281
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Preparation of pyrrolidine and isoxazolidine benzamidines as potent inhibitors of coagulation factor Xa.
    Fevig JM; Buriak J; Stouten PF; Knabb RM; Lam GN; Wong PC; Wexler RR
    Bioorg Med Chem Lett; 1999 Apr; 9(8):1195-200. PubMed ID: 10328312
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Synthesis of Fucosylated Chondroitin Sulfate Nonasaccharide as a Novel Anticoagulant Targeting Intrinsic Factor Xase Complex.
    Zhang X; Liu H; Lin L; Yao W; Zhao J; Wu M; Li Z
    Angew Chem Int Ed Engl; 2018 Sep; 57(39):12880-12885. PubMed ID: 30067300
    [TBL] [Abstract][Full Text] [Related]  

  • 39. At-line nanofractionation with parallel mass spectrometry and bioactivity assessment for the rapid screening of thrombin and factor Xa inhibitors in snake venoms.
    Mladic M; Zietek BM; Iyer JK; Hermarij P; Niessen WM; Somsen GW; Kini RM; Kool J
    Toxicon; 2016 Feb; 110():79-89. PubMed ID: 26708656
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Selective inhibition of the prothrombinase complex: factor Va alters macromolecular recognition of a tick anticoagulant peptide mutant by factor Xa.
    Betz A; Vlasuk GP; Bergum PW; Krishnaswamy S
    Biochemistry; 1997 Jan; 36(1):181-91. PubMed ID: 8993332
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.